Medicare Enrolled

Dr. Ann Anderson, MD

Clinical Pathology/Laboratory Medicine Physician · Garden City, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
700 STEWART AVE STE 101, Garden City, NY 11530
5162807930
Registered in NPPES since 2006
NPI: 1154492247 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Anderson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Anderson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Anderson

Dr. Ann Anderson is a clinical pathology/laboratory medicine physician in Garden City, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Anderson performed 109,251 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Anderson received a total of $181 from 6 pharmaceutical and/or device companies across 6 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Anderson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 2% volume in NY $181 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
109,251
Medicare services
Top 2% in NY for clinical pathology/laboratory medicine physician
Not available
Unique patients (not deduplicated)
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Infectious disease DNA/RNA test
A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism.
43,807 $34 $105
Genetic analysis to identify organisms
A laboratory test that uses genetic analysis and an amplified probe technique to identify specific organisms.
40,237 $34 $105
Molecular pathology test interpretation
A physician reviews and interprets the results of a molecular pathology test to provide a diagnostic report.
3,917 $40 $159
TB DNA amplification test
A laboratory test that uses DNA amplification to detect the presence of tuberculosis bacteria in a sample.
3,354 $41 $125
Staphylococcus aureus DNA test
A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample.
3,354 $34 $105
Strep A nucleic acid amplification test
A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present.
3,354 $34 $105
Yeast/candida DNA test
A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample.
3,353 $34 $105
Group B Strep DNA test
A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria.
3,353 $34 $105
VRE nucleic acid detection test
A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample.
3,352 $34 $105
PALB2 gene full sequence analysis
A genetic test that examines the complete sequence of the PALB2 gene to identify mutations. This analysis helps determine if there are changes in the DNA that may affect cancer risk.
554 $663 $2,030
BRCA1 and BRCA2 gene analysis
A genetic test that examines the full sequence of the BRCA1 and BRCA2 genes to detect duplication or deletion variants.
543 $1,788 $5,475
Manual urine cell examination
A laboratory test where a technician manually examines a urine sample under a microscope to identify and count cells.
18 $584 $2,130
MLH1 gene full sequence analysis
A laboratory test that examines the complete DNA sequence of the MLH1 gene to identify mutations associated with hereditary nonpolyposis colon cancer.
11 $662 $2,026
MUTYH gene full sequence analysis
A genetic test that examines the complete sequence of the MUTYH gene to identify mutations associated with nonpolyposis colon cancer.
11 $374 $1,145
Full sequence analysis of MSH6 gene
A genetic test that examines the complete sequence of the MSH6 gene to identify any mutations or variations.
11 $629 $1,926
Gene analysis, full sequence
A laboratory test that determines the complete DNA sequence of a specific gene. This analysis identifies variations in the genetic code to assess biological characteristics.
11 $663 $2,030
Molecular pathology procedure level 9
A high-complexity molecular pathology test involving advanced genetic or genomic analysis. This level indicates the most complex type of molecular diagnostic procedure performed.
11 $1,960 $6,000
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$181
Total received (2018-2024)
Avg $45/year across 4 years
Top 39% in NY for clinical pathology/laboratory medicine physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
6
Companies
6
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$74
2023
$25
2019
$15
2018
$68

Payments by company (2024)

Illumina, Inc.
$27
Myriad Genetic Laboratories, Inc.
$24
Roche Diagnostics Corporation
$22
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$68
Illumina, Inc.
$27
IBSA Pharma Inc.
$25
Myriad Genetic Laboratories, Inc.
$24
Roche Diagnostics Corporation
$22
Genentech USA, Inc.
$15
Top 3 companies account for 66.3% of all-time payments
Associated products mentioned in payments ›
LICART · Oncology Testing · PROLARIS · VIRTUOSO System for IHC
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a clinical pathology/laboratory medicine physician in Garden City?
Compare clinical pathology/laboratory medicine physicians in the Garden City area by procedure volume, costs, and industry payment transparency.
Browse clinical pathology/laboratory medicine physicians nearby

Geographic Context

Clinical pathology/laboratory medicine physicians in nearby ZIP areas
55
County median income
$143,408
Nearest hospital to ZIP centroid (approximate)
LONG ISLAND JEWISH MEDICAL CENTER
2.6 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Anderson is a mixed practice specialist, with above-average Medicare volume (top 2% in NY), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Anderson experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Anderson performed 43,807 infectious disease dna/rna test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Anderson receive payments from pharmaceutical companies?
Yes. Dr. Anderson received a total of $181 from 6 companies across 6 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Anderson's costs compare to other clinical pathology/laboratory medicine physicians in Garden City?
Dr. Anderson's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Anderson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →